SAN CLEMENTE, Calif., May 2, 2006 (PRIMEZONE) -- As a result of reporting requirements relating to certain discontinued operations, Advanced Refractive Technologies, Inc. is late in its filing of the 10K for the fiscal year ending 12/31/05. The auditors should complete the audit by the second week in May and all filings will be brought up to date.
About Advanced Refractive Technologies, Inc.
Advanced Refractive Technologies, Inc. is a medical device company focused on the development and marketing of innovative ophthalmic applications that will result in faster, safer and more effective procedures in two of the largest surgical markets in the world: corrective refractive surgery and cataract surgery. The Company is also entering the area of drug discovery through strategic licensing opportunities. Advanced Refractive Technologies is also in the process of developing their Accupulse, a next generation cataract emulsifier, which utilizes the company's proprietary waterjet technology. The Accupulse cataract emulsifier, currently under development, is a device that uses pulsed waterjet technology to remove cataracts -- the most frequently performed surgical procedure in the world. For more information on Advanced Refractive Technologies, please visit its website at www.advancedrefractive.com
The Advanced Refractive Technologies, Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=2498